INTERNATIONAL PATENT: THERIVA BIOLOGICS, S.L. FILES APPLICATION FOR "ONCOLYTIC ADENOVIRUS AND TOPOISOMERASE I INHIBITORS FOR USE IN TREATING A CANCER"

GENEVA, March 31 -- THERIVA BIOLOGICS, S.L. (Sant Cugat del Valles08174 Barcelona Barcelona) filed a patent application (PCT/IB2024/059165) for "ONCOLYTIC ADENOVIRUS AND TOPOISOMERASE I INHIBITORS FOR USE IN TREATING A CANCER" on Sep 20, 2024. With publication no. WO/2025/062359, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CONNELLY, Sheila (c/o Theriva Biologics, Inc.9605 Medical Center Dr., Suite 270Rockville, Maryland 20850), MATO BERCIANO, Ana (c/o Theriva Biologics, Inc.9605 Medical Center Dr., Suite 270Rockville,...